Clearside Biomedical, Inc. Quarterly Depreciation in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Clearside Biomedical, Inc. annual/quarterly Depreciation history and growth rate from Q1 2016 to Q1 2024.
  • Clearside Biomedical, Inc. Depreciation for the quarter ending March 31, 2024 was $28K, a 86.7% increase year-over-year.
  • Clearside Biomedical, Inc. annual Depreciation for 2024 was $226K, a 237% increase from 2023.
  • Clearside Biomedical, Inc. annual Depreciation for 2023 was $67K, a 53.8% decline from 2022.
  • Clearside Biomedical, Inc. annual Depreciation for 2022 was $145K, a 18.5% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $28K +$13K +86.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 $15K -$31K -67.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $46K +$1K +2.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $45K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $45K -$8K -15.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $53K +$6K +12.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $47K +$17K +56.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $30K +$13K +76.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $17K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.